How should low‑dose topical estrogen cream be used to treat vulvar itching in a postmenopausal woman, and what are the contraindications? | Rounds How should low‑dose topical estrogen cream be used to treat vulvar itching in a postmenopausal woman, and what are the contraindications? | Rounds
Loading...

How should low‑dose topical estrogen cream be used to treat vulvar itching in a postmenopausal woman, and what are the contraindications?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Low-dose topical vaginal estrogen for vulvovaginal itching

Low-dose vaginal estrogen (estradiol 0.01% cream) is indicated for menopausal vulvovaginal atrophy symptoms, which can present as vulvovaginal itching. [1]

Dosing and administration

Low-dose estradiol vaginal cream is administered as intravaginal therapy using the calibrated applicator. [1]

Usual dosing for menopausal vulvar/vaginal atrophy is:

  • 2 to 4 g daily for 1 to 2 weeks. [1]
  • Then gradual reduction to one half of the initial dose for a similar period. [1]
  • Maintenance dosing of 1 g, one to three times per week after restoration of vaginal mucosa is achieved. [1]

Application instructions emphasize correct use of the provided applicator and calibrated dosing. [1]

Contraindications

Estradiol vaginal cream should not be used in the presence of any of the following:

  • Undiagnosed abnormal genital bleeding. [1]
  • Known, suspected, or history of breast cancer. [1]
  • Known or suspected estrogen-dependent neoplasia. [1]
  • Active deep vein thrombosis (DVT) or pulmonary embolism (PE) or history of these conditions. [1]
  • Active arterial thromboembolic disease (examples include stroke or myocardial infarction) or history of these conditions. [1]
  • Known anaphylactic reaction or angioedema to estradiol vaginal cream, 0.01%. [1]
  • Known liver dysfunction or disease. [1]
  • Known protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders. [1]
  • Known or suspected pregnancy. [1]

Systemic absorption may occur with use of this local estrogen preparation. [1]

Related Questions